216 related articles for article (PubMed ID: 17253780)
1. X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase.
Sugishima M; Higashimoto Y; Oishi T; Takahashi H; Sakamoto H; Noguchi M; Fukuyama K
Biochemistry; 2007 Feb; 46(7):1860-7. PubMed ID: 17253780
[TBL] [Abstract][Full Text] [Related]
2. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors.
Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
J Med Chem; 2006 Jul; 49(14):4437-41. PubMed ID: 16821802
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode.
Rahman MN; Vlahakis JZ; Vukomanovic D; Szarek WA; Nakatsu K; Jia Z
J Med Chem; 2009 Aug; 52(15):4946-50. PubMed ID: 19601578
[TBL] [Abstract][Full Text] [Related]
4. X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors.
Rahman MN; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
J Med Chem; 2008 Oct; 51(19):5943-52. PubMed ID: 18798608
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone.
Roman G; Rahman MN; Vukomanovic D; Jia Z; Nakatsu K; Szarek WA
Chem Biol Drug Des; 2010 Jan; 75(1):68-90. PubMed ID: 19954435
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.
Kinobe RT; Vlahakis JZ; Vreman HJ; Stevenson DK; Brien JF; Szarek WA; Nakatsu K
Br J Pharmacol; 2006 Feb; 147(3):307-15. PubMed ID: 16331285
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring.
Vlahakis JZ; Hum M; Rahman MN; Jia Z; Nakatsu K; Szarek WA
Bioorg Med Chem; 2009 Mar; 17(6):2461-75. PubMed ID: 19268600
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of novel imidazole-dioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells.
Kinobe RT; Ji Y; Vlahakis JZ; Motterlini R; Brien JF; Szarek WA; Nakatsu K
J Pharmacol Exp Ther; 2007 Dec; 323(3):763-70. PubMed ID: 17761847
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of ferrous and ferrous-NO forms of verdoheme in a complex with human heme oxygenase-1: catalytic implications for heme cleavage.
Lad L; Ortiz de Montellano PR; Poulos TL
J Inorg Biochem; 2004 Nov; 98(11):1686-95. PubMed ID: 15522396
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of ferrous and CO-, CN(-)-, and NO-bound forms of rat heme oxygenase-1 (HO-1) in complex with heme: structural implications for discrimination between CO and O2 in HO-1.
Sugishima M; Sakamoto H; Noguchi M; Fukuyama K
Biochemistry; 2003 Aug; 42(33):9898-905. PubMed ID: 12924938
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human heme oxygenase-1 in a complex with biliverdin.
Lad L; Friedman J; Li H; Bhaskar B; Ortiz de Montellano PR; Poulos TL
Biochemistry; 2004 Apr; 43(13):3793-801. PubMed ID: 15049686
[TBL] [Abstract][Full Text] [Related]
12. Heme oxygenase inhibition by 1-aryl-2-(1h-imidazol-1-yl/1h-1,2,4-triazol-1-yl)ethanones and their derivatives.
Roman G; Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
ChemMedChem; 2010 Sep; 5(9):1541-55. PubMed ID: 20652928
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic studies of heme oxygenase complexed with an unstable reaction intermediate, verdoheme.
Unno M; Matsui T; Ikeda-Saito M
J Inorg Biochem; 2012 Aug; 113():102-9. PubMed ID: 22673156
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of rat heme oxygenase-1 in complex with biliverdin-iron chelate. Conformational change of the distal helix during the heme cleavage reaction.
Sugishima M; Sakamoto H; Higashimoto Y; Noguchi M; Fukuyama K
J Biol Chem; 2003 Aug; 278(34):32352-8. PubMed ID: 12794075
[TBL] [Abstract][Full Text] [Related]
15. Isocyanides inhibit human heme oxygenases at the verdoheme stage.
Evans JP; Kandel S; Ortiz de Montellano PR
Biochemistry; 2009 Sep; 48(37):8920-8. PubMed ID: 19694439
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of heme oxygenase-1 from cyanobacterium Synechocystis sp. PCC 6803 in complex with heme.
Sugishima M; Migita CT; Zhang X; Yoshida T; Fukuyama K
Eur J Biochem; 2004 Nov; 271(22):4517-25. PubMed ID: 15560792
[TBL] [Abstract][Full Text] [Related]
17. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors.
Vukomanovic D; McLaughlin B; Rahman MN; Vlahakis JZ; Roman G; Dercho RA; Kinobe RT; Hum M; Brien JF; Jia Z; Szarek WA; Nakatsu K
Can J Physiol Pharmacol; 2010 Apr; 88(4):480-6. PubMed ID: 20555417
[TBL] [Abstract][Full Text] [Related]
18. CO-trapping site in heme oxygenase revealed by photolysis of its co-bound heme complex: mechanism of escaping from product inhibition.
Sugishima M; Sakamoto H; Noguchi M; Fukuyama K
J Mol Biol; 2004 Jul; 341(1):7-13. PubMed ID: 15312758
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of rat apo-heme oxygenase-1 (HO-1): mechanism of heme binding in HO-1 inferred from structural comparison of the apo and heme complex forms.
Sugishima M; Sakamoto H; Kakuta Y; Omata Y; Hayashi S; Noguchi M; Fukuyama K
Biochemistry; 2002 Jun; 41(23):7293-300. PubMed ID: 12044160
[TBL] [Abstract][Full Text] [Related]
20. Alkyl peroxides reveal the ring opening mechanism of verdoheme catalyzed by heme oxygenase.
Matsui T; Omori K; Jin H; Ikeda-Saito M
J Am Chem Soc; 2008 Apr; 130(13):4220-1. PubMed ID: 18331037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
